423 related articles for article (PubMed ID: 29545008)
1. The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.
Clayton AH; Goldstein I; Kim NN; Althof SE; Faubion SS; Faught BM; Parish SJ; Simon JA; Vignozzi L; Christiansen K; Davis SR; Freedman MA; Kingsberg SA; Kirana PS; Larkin L; McCabe M; Sadovsky R
Mayo Clin Proc; 2018 Apr; 93(4):467-487. PubMed ID: 29545008
[TBL] [Abstract][Full Text] [Related]
2. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Womens Health (Larchmt); 2021 Apr; 30(4):474-491. PubMed ID: 33797277
[No Abstract] [Full Text] [Related]
3. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Sex Med; 2021 May; 18(5):849-867. PubMed ID: 33814355
[TBL] [Abstract][Full Text] [Related]
4. Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
Kingsberg SA; Simon JA
J Womens Health (Larchmt); 2020 Aug; 29(8):1101-1112. PubMed ID: 32460605
[TBL] [Abstract][Full Text] [Related]
5. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
Climacteric; 2021 Dec; 24(6):533-550. PubMed ID: 33792440
[TBL] [Abstract][Full Text] [Related]
6. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Goldstein I; Kim NN; Clayton AH; DeRogatis LR; Giraldi A; Parish SJ; Pfaus J; Simon JA; Kingsberg SA; Meston C; Stahl SM; Wallen K; Worsley R
Mayo Clin Proc; 2017 Jan; 92(1):114-128. PubMed ID: 27916394
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
DeRogatis LR; Allgood A; Auerbach P; Eubank D; Greist J; Bharmal M; Zipfel L; Guo CY
J Sex Med; 2010 Feb; 7(2 Pt 2):917-27. PubMed ID: 19832932
[TBL] [Abstract][Full Text] [Related]
8. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
9. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
[TBL] [Abstract][Full Text] [Related]
11. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).
Leiblum SR; Koochaki PE; Rodenberg CA; Barton IP; Rosen RC
Menopause; 2006; 13(1):46-56. PubMed ID: 16607098
[TBL] [Abstract][Full Text] [Related]
12. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.
Dennerstein L; Koochaki P; Barton I; Graziottin A
J Sex Med; 2006 Mar; 3(2):212-22. PubMed ID: 16490014
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Management of Hypoactive Sexual Desire Disorder.
Clayton AH; Kingsberg SA; Goldstein I
Sex Med; 2018 Jun; 6(2):59-74. PubMed ID: 29523488
[TBL] [Abstract][Full Text] [Related]
14. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
Parish SJ; Hahn SR
Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
[TBL] [Abstract][Full Text] [Related]
15. Flibanserin and its discontents.
Aftab A; Chen C; McBride J
Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
[TBL] [Abstract][Full Text] [Related]
16. Female hypoactive sexual desire disorder: History and current status.
Segraves R; Woodard T
J Sex Med; 2006 May; 3(3):408-18. PubMed ID: 16681466
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
18. Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.
Warnock JK; Clayton A; Croft H; Segraves R; Biggs FC
J Sex Med; 2006 Sep; 3(5):878-882. PubMed ID: 16942531
[TBL] [Abstract][Full Text] [Related]
19. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
20. Aromatase Inhibitors Are Associated With Low Sexual Desire Causing Distress and Fecal Incontinence in Women: An Observational Study.
Robinson PJ; Bell RJ; Christakis MK; Ivezic SR; Davis SR
J Sex Med; 2017 Dec; 14(12):1566-1574. PubMed ID: 29066307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]